CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
Silvio Danese, Rupa Banerjee, JR Fraser Cummings, Iris Dotan, Paulo G Kotze, Rupert Wing Loong Leong, Kristine Paridaens, Laurent Peyrin-Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K Yamamoto-Furusho
Intest Res. 2018;16(4):522-528.   Published online October 16, 2018
DOI: https://doi.org/10.5217/ir.2018.00073

Excel Download

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
Intestinal Research. 2018;16(4):522-528   Crossref logo
Link1 Link2 Link3

Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool
Gastroenterology. 2019;156(3):765   Crossref logo
Link1 Link2

Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide
Gastroenterology. 2019;156(3):766-767   Crossref logo
Link1 Link2

Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: Infliximab
Crohn's Disease and Ulcerative Colitis. 2017;429-433   Crossref logo
Link1

Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis
Journal of the American Academy of Nurse Practitioners. 2010;22(11):586-592   Crossref logo
Link1

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
Intestinal Research. 2018;16(2):163   Crossref logo
Link1 Link2 Link3

Once dailyvsmultiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis
Colorectal Disease. 2016;18(7):O214-O223   Crossref logo
Link1

Biologic Therapy of Ulcerative Colitis: Adalimumab
Crohn's Disease and Ulcerative Colitis. 2017;435-439   Crossref logo
Link1

487. Treatment of Experimental Ulcerative Colitis by Mesenchymal Stem Cells Expressing Interleukin-35
Molecular Therapy. 2014;22:S187   Crossref logo
Link1 Link2

Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis
Journal of Gastroenterology and Hepatology. 2014;29(6):1159-1170   Crossref logo
Link1